Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying a predictive model for response to atypical antipsychotic monotherapy treatment in south Indian schizophrenia patients.

Genomics - 1 Aug 2013

Gupta Meenal, Moily Nagaraj S, Kaur Harpreet, Jajodia Ajay, Jain Sanjeev, Kukreti Ritushree

Abstract excerpt

Atypical antipsychotic (AAP) drugs are the preferred choice of treatment for schizophrenia patients. Patients who do not show favorable response to AAP monotherapy are subjected to random prolonged therapeutic treatment with AAP multitherapy, typical antipsychotics or a combination of both. Therefore, prior identification of patients' response to drugs can be an important step in providing efficacious and safe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to India

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Regression Analysis

Share to Reproducibility of Results

Share to Schizophrenia

Source

Identifiers

PMID: 23402766
DOI: 10.1016/j.ygeno.2013.02.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying a predictive model for response to atypical antipsychotic monotherapy treatment in south Indian schizophrenia patients.PMID 23402766Read ↗

A computational algorithm for personalized medicine in schizophrenia.Semantic proximity Read ↗

Synergistic association of PI4KA and GRM3 genetic polymorphisms with poor antipsychotic response in south Indian schizophrenia patients with low severity of illness.Semantic proximity Read ↗

Antipsychotic drug dosage and therapeutic response in schizophrenia is influenced by ABCB1 genotypes: a study from a south Indian perspective.Semantic proximity Read ↗

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia PatientsSemantic proximity Read ↗

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.Semantic proximity Read ↗

Prediction of antipsychotics efficacy based on a polygenic risk score: a real-world cohort studySemantic proximity Read ↗

Association of 5-HTR2A T102C and A-1438G polymorphisms with clinical response to atypical antipsychotic treatment in schizophrenia: A meta-analysis.Semantic proximity Read ↗

CACNA1C gene and schizophrenia: a case-control and pharmacogenetic study.Semantic proximity Read ↗

Association of the genetic polymorphisms of metabolizing enzymes, transporters, target receptors and their interactions with treatment response to olanzapine in chinese han schizophrenia patients.Semantic proximity Read ↗

Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort.Semantic proximity Read ↗

Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study.Semantic proximity Read ↗

Clinical and genetic correlates of severity in schizophrenia in India: an ordinal logistic regression approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.